The rate of dasotraline brain entry is slow following intravenous administration
Sign Up to like & getrecommendations! Published in 2020 at "Psychopharmacology"
DOI: 10.1007/s00213-020-05623-8
Abstract: Drugs that rapidly increase dopamine levels have an increased risk of abuse. Dasotraline (DAS) is a dopamine and norepinephrine reuptake inhibitor characterized by slow oral absorption with low potential for abuse. However, it remains unclear… read more here.
Keywords: intravenous administration; administration; brain entry; dopamine ... See more keywords